Integra LifeSciences Corporation
IART | NASDAQ
$16.12
+$0.53 (+3.40%)
Sep 22, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 235.05M | 246.38M | 276.4M | 456.66M | 513.45M | 470.17M |
Short-Term Investments | 28.69M | 27.19M | 32.69M | n/a | n/a | n/a |
Long-Term Investments | 12.78M | 38.3M | 30.71M | 567.34M | 6.48M | 474.83M |
Other Long-Term Assets | 25.1M | 28.21M | 27.48M | -510.15M | 9.96M | -463.56M |
Receivables | 278.85M | 272.37M | 259.33M | 263.47M | 243.24M | 225.53M |
Inventory | 492.74M | 429.09M | 389.61M | 324.58M | 317.39M | 310.12M |
Other Current Assets | 28.13M | 29.65M | 32.64M | 31.03M | 13.82M | 162.11M |
Total Current Assets | 1.16B | 1.08B | 1.06B | 1.16B | 1.15B | 1.24B |
Property-Plant & Equipment | 584.9M | 549.77M | 496.38M | 459.59M | 396.25M | 371.16M |
Goodwill & Intangibles | 1.75B | 2.3B | 2.12B | 2.17B | 2.16B | 1.92B |
Total Long-Term Assets | 2.44B | 2.96B | 2.72B | 2.73B | 2.63B | 2.38B |
Total Assets | 3.6B | 4.04B | 3.78B | 3.89B | 3.78B | 3.62B |
Account Payables | 95.73M | 82.5M | 92.33M | 102.1M | 61.84M | 54.61M |
Deferred Revenue | 11.46M | 10.48M | 8.54M | 7.25M | 5.3M | 5.28M |
Short-Term Debt | 126.55M | 607.08M | 14.53M | 52.75M | 59.78M | 146.25M |
Other Current Liabilities | 74.08M | 37.79M | 100.84M | 65.41M | 105.68M | 105.95M |
Total Current Liabilities | 455.98M | 922.13M | 306.98M | 320.91M | 340.02M | 401.01M |
Long-Term Debt | 1.73B | 1.2B | 1.49B | 1.41B | 1.5B | 1.41B |
Other Long-Term Liabilities | 204.28M | 137.04M | 192.24M | 138.5M | 120.26M | 186.73M |
Total Long-Term Liabilities | 2.1B | 1.57B | 1.89B | 1.76B | 1.76B | 1.7B |
Total Liabilities | 2.56B | 2.49B | 2.19B | 2.09B | 2.1B | 2.1B |
Total Debt | 2.03B | 1.98B | 1.68B | 1.63B | 1.67B | 1.66B |
Book Value | 1.04B | 1.55B | 1.59B | 1.8B | 1.68B | 1.51B |
Book Value Per Share | 13.60 | 20.07 | 19.77 | 21.61 | 19.71 | 17.77 |
Common Stock | 923K | 916K | 909K | 905K | 896K | 893K |
Retained Earnings | 423.44M | 939.92M | 946.86M | 879.12M | 698.57M | 532.27M |
Comprehensive Income | -30.08M | -27.57M | -15.11M | 10.27M | -45.16M | -74.06M |
Shareholders Equity | 1.04B | 1.55B | 1.59B | 1.8B | 1.68B | 1.51B |
Total Investments | 41.47M | 65.49M | 63.4M | 567.34M | 6.48M | 474.83M |
Add to Watchlist
Select watchlists to add or remove IART